1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Locoregional Therapy Combined With Bevacizumab and PD1/L1 Inhibitor in Advanced Hepatocellular CarcinomaAdvanced Hepatocellular Carcinoma; Anti-PD1/PDL1 Antibody; BevacizumabRecruitingNot stated2025-08-14NCT06323382